Back to results
US 2006/0039890 A1Published application
Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant
OwnerPerry Renshaw, Bruce Coheninventors
Life of this patent
Estimating the term…
Abstract
The present invention features compositions, kits, and methods for treating or reducing a cognitive or psychological disorder, such as depression.
Claims66
A composition comprising a cholesterol-lowering agent and an antidepressant, wherein said cholesterol-lowering agent and antidepressant are present in amounts that, when administered to a human, are sufficient to treat or reduce the severity of a cognitive or psychological disorder.
A method comprising:
- (a) performing a diagnostic test on a patient to determine whether said patient has a cognitive or psychological disorder, and
- b) if said patient is diagnosed with a cognitive or psychological disorder, administering to said patient a cholesterol-lowering agent and an antidepressant in amounts sufficient to treat or reduce the severity of said cognitive or psychological disorder.
A kit comprising:
- (a) a cholesterol-lowering agent in an amount sufficient to lower the serum cholesterol of, and increase the membrane fluidity of neuronal cells in, a patient administered said cholesterol-lowering agent;
- and
- (b) instructions for administering said cholesterol-lowering agent and an antidepressant to a patient for the treatment of, or reduction in severity of, a cognitive or psychological disorder.
A kit comprising:
- (a) an antidepressant;
- and
- (b) instructions for administering said antidepressant and a cholesterol-lowering agent to a patient for the treatment of, or reduction in severity of, a cognitive or psychological disorder.
A kit comprising:
- (a) a composition comprising a cholesterol-lowering agent and an antidepressant;
- and
- (b) instructions for administering said composition to a patient for the treatment of, or reduction in severity of, a cognitive or psychological disorder.
A kit comprising:
- (a) a cholesterol-lowering agent in an amount sufficient to lower the serum cholesterol of, and increase the membrane fluidity of neuronal cells in, a patient administered said cholesterol-lowering agent;
- (b) an antidepressant;
- and
- (c) instructions for administering said cholesterol-lowering agent and said antidepressant to a patient for the treatment of, or reduction in severity of, a cognitive or psychological disorder.
1 more element
Dependencies are inferred from the claim text.